Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jörn, Risse"'
Autor:
K. Reichmann, M. Damm, H. J. Biersack, Samer Ezziddin, Jörn Risse, Hojjat Ahmadzadehfar, Amin Sabet, S. Guhlke, T. Logvinski, C. J. Yong-Hing
Publikováno v:
Nuklearmedizin. 52:170-177
Summary[177Lu-DOTA0, Tyr3]-octreotate (177Lu-octreotate) in peptide receptor radionuclide therapy (PRRT) offers direct intra-therapeutic dosimetry. The aim of this study was to compare tumour and non-tumour parameters and assess intra-individual vari
Publikováno v:
Methods. 55:246-252
The incidence of hepatocellular carcinoma (HCC) is worldwide sharply on the rise and patients with advanced disease carry a poor prognosis. HCC is the sixth most common cancer and the third leading cause of cancer associated deaths in the world. Intr
Autor:
Christian Rabe, Jan Bucerius, Hans-Peter Fischer, Dirk Pauleit, Jörn Risse, Hans Bender, Hans-Jürgen Biersack
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 24:445-452
The diagnostic accuracy of 18F-FDG-PET (fluoro-2-deoxyglucose-positron emission tomography) remains questionable for primary hepatocellular carcinoma (HCC) but seems to be more promising for restaging and therapy control. Yet, there are no data on FD
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 22:740-747
Positron-emission tomography (PET) employing fluorodeoxyglucose (FDG) has proven to be a highly sensitive and specific diagnostic method in the staging and restaging of various neoplasms, including melanoma, complementing morphologic imaging. FDG upt
Autor:
Hans-Jürgen Biersack, Jörn Risse, Frank Grünwald, Verena Klein, Jan Bucerius, Samer Ezziddin, K. Reichmann, Hans Bender, Dirk Pauleit, Holger Palmedo
Publikováno v:
Nuklearmedizin. 46:192-197
SummaryAim: Dosimetry in 131I-lipiodol therapy for hepatocellular carcinoma (HCC) in the hitherto largest existing patient cohort. Patients, methods: 38 courses of intra-arterial 131I-lipiodol therapy with a total activity up to 6.7 GBq were performe
Autor:
H. Strunk, H. Palmedo, Jörn Risse, C. Menzel, K. Reichmann, Dirk Pauleit, Frank Grünwald, C. Rabe, H. J. Biersack
Publikováno v:
Nuklearmedizin. 45:185-192
SummaryAim: To evaluate the efficacy and tolerance of iodine- 131-lipiodol (131I-lipiodol) for hepatocellular carcinoma (HCC) in German long term patients and comparison with medically treated controls. Patients, Methods: 38 courses of intra-arterial
Autor:
Frank Grünwald, Jürgen Freyschmidt, N. Hamscho, M. Diehl, Sonali Sengupta, Thomas J. Vogl, Jörn Risse
Publikováno v:
European Journal of Radiology Extra. 52:41-46
Purpose: Erdheim Chester disease is a rare form of histiocytosis, affecting the skeleton and various inner organs. One hundred and twenty-five publications have reported radiographic and bone scintigraphic studies in the English speaking literature.
Autor:
Jörn Risse, Christian Menzel, Hans-Jürgen Biersack, Jürgen K. Rockstroh, M. Bangard, Holger Palmedo, Karin Schliefer
Publikováno v:
Radiology. 221:256-260
Eight patients (77 joints) with polyarthritis were treated systemically with 570 MBq (15.4 mCi) of rhenium 186 ((186)Re) hydroxyethylidenediphosphonate (HEDP). Pain and disease activity were assessed monthly. In six (75%) of eight patients, a single
Autor:
S. Arens, A. Schmitz, Thomas Kälicke, Hans J. Biersack, M. Hansis, Ewald Keller, Ottmar Schmitt, Jörn Risse, Frank Grünwald
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 27:524-528
The aim of this study was to evaluate the clinical use of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) in acute and chronic osteomyelitis and inflammatory spondylitis. The study population comprised 21 patients suspected of h
Autor:
Jörn Risse, G. Schoeneich, Holger Palmedo, Furn F. Knapp, Hans Bender, J. Sartor, Frank Grünwald, Hans-Jürgen Biersack, Stefan Guhlke
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 27:123-130
The aim of this study was to determine the maximum tolerated dose of rhenium-188 hydroxyethylidene diphosphonate (HEDP) in prostate cancer patients with osseous metastases who are suffering from bone pain. Twenty-two patients received a single inject